| EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus J Lindblom, A Gomez, A Borg, S Emamikia, D Ladakis, J Matilla, M Pehr, ... Rheumatology 60 (10), 4703-4716, 2021 | 17 | 2021 |
| Mitochondrial measures in neuronally enriched extracellular vesicles predict brain and retinal atrophy in multiple sclerosis DC Ladakis, PJ Yao, M Vreones, J Blommer, G Kalaitzidis, ES Sotirchos, ... Multiple Sclerosis Journal 28 (13), 2020-2026, 2022 | 8 | 2022 |
| Myeloid cell-associated aromatic amino acid metabolism facilitates CNS myelin regeneration J Hu, GS Melchor, D Ladakis, J Reger, HW Kim, KA Chamberlain, ... npj Regenerative Medicine 9 (1), 1, 2024 | 7 | 2024 |
| Metabolomics of multiple sclerosis lesions demonstrates lipid changes linked to alterations in transcriptomics-based cellular profiles DC Ladakis, E Pedrini, MI Reyes-Mantilla, M Sanjayan, MD Smith, ... Neurology: Neuroimmunology & Neuroinflammation 11 (3), e200219, 2024 | 5 | 2024 |
| Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease DC Ladakis, KL Harrison, MD Smith, K Solem, S Gadani, L Jank, ... Med, 2024 | 4 | 2024 |
| Ocrelizumab alters the circulating metabolome in people with relapsing–remitting multiple sclerosis F Siavoshi, DC Ladakis, A Muller, B Nourbakhsh, P Bhargava Annals of Clinical and Translational Neurology 11 (9), 2485-2498, 2024 | 3 | 2024 |
| Several serum lipid metabolites are associated with relapse risk in pediatric-onset multiple sclerosis A Virupakshaiah, DC Ladakis, B Nourbakhsh, P Bhargava, S Dilwali, ... Multiple Sclerosis Journal 29 (8), 936-944, 2023 | 3 | 2023 |
| Fatigue is a common symptom in myelin oligodendrocyte glycoprotein antibody disease DC Ladakis, J Gould, JM Khazen, JM Lefelar, S Tarpey, CJ Bies, R Salky, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 8 (4 …, 2022 | 3 | 2022 |
| Serum lipidomics and disease activity in pediatric-onset multiple sclerosis: a nation-wide prospective cohort study V Schoeps, K Borkowski, D Ladakis, A Virupakshaiah, P Bhargava, ... MULTIPLE SCLEROSIS JOURNAL 29, 61-62, 2023 | 2 | 2023 |
| Visual pathway involvement in NMDA receptor encephalitis: a clinical, optical coherence tomography, and 18-fluorodeoxyglucose PET/CT approach G Kalaitzidis, A Filippatou, N Fioravante, A Rothman, ES Sotirchos, ... Journal of Neuro-Ophthalmology 43 (2), 220-226, 2023 | 2 | 2023 |
| Restoring the Multiple Sclerosis Associated Imbalance of Gut Indole Metabolites Promotes Remyelination and Suppresses Neuroinflammation L Jank, SS Singh, J Lee, A Dhukhwa, F Siavoshi, D Joshi, V Minney, ... bioRxiv, 2024.10. 27.620437, 2025 | 1 | 2025 |
| Synaptic protein loss in extracellular vesicles reflects brain and retinal atrophy in people with multiple sclerosis DC Ladakis, M Vreones, J Blommer, KL Harrison, MD Smith, ES Vasileiou, ... Neurology: Neuroimmunology & Neuroinflammation 11 (4), e200257, 2024 | 1 | 2024 |
| Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosis DC Ladakis, MI Reyes-Mantilla, SP Gadani, JW Mace, ... Multiple Sclerosis Journal 30 (1), 35-43, 2024 | 1 | 2024 |
| The role of gut dysbiosis and potential approaches to target the gut microbiota in multiple sclerosis DC Ladakis, P Bhargava CNS drugs 37 (2), 117-132, 2023 | 1 | 2023 |
| Hemi-macular atrophy in multiple sclerosis: a potential representation of trans-synaptic neurodegeneration extending beyond the inner retina G Kalaitzidis, H Moussa, D Ladakis, J Lambe, A Filippatou, E Vasileiou, ... Multiple Sclerosis Journal 28 (3_ SUPPL), 578-579, 2022 | 1 | 2022 |
| Distinct plasma lipids predict axonal injury and multiple sclerosis activity VA Schoeps, P Bhargava, A Virupakshaiah, DC Ladakis, C Moseley, ... Journal of Neurology, Neurosurgery & Psychiatry 96 (2), 150-157, 2025 | | 2025 |
| Telomere length as a marker of biological age in pediatric multiple sclerosis K Jacques, C Goyne, A Fair, A Schuette, J Race, G Aaen, A Abrams, ... MULTIPLE SCLEROSIS JOURNAL 30 (3), 224-225, 2024 | | 2024 |
| Metabolomic profiles associated with disease severity in multiple sclerosis F Siavoshi, D Ladakis, P Bhargava MULTIPLE SCLEROSIS JOURNAL 30 (3), 177-178, 2024 | | 2024 |
| The Association of Tryptophan Metabolites and Gut Tryptophan-metabolizing Bacteria with MS-related Symptoms and Disease Severity F Siavoshi, D Ladakis, P Bhargava MULTIPLE SCLEROSIS JOURNAL 30 (3), 738-739, 2024 | | 2024 |
| Quality of life is impaired in myelin oligodendrocyte glycoprotein antibody associated disease Y Said, DC Ladakis, JM Lefelar, JM Khazen, J Gould, KC Fitzgerald, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 10 (3 …, 2024 | | 2024 |